Navigation Links
Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing
Date:4/15/2008

- Second research program centered on potential target in inflammatory

indications such as rheumatoid arthritis -

NUTLEY, N.J., April 15 /PRNewswire/ -- Roche announced today that it will acquire Piramed Limited, a privately-owned UK company focusing on therapeutics targeting PI3-kinase (PI3-K). The PI3-K pathway is known to play an important role in disease progression and in resistance to chemotherapeutics in cancer cells. Pre-clinical studies have demonstrated the activity of PI3-K inhibitors in a broad range of tumors such as breast and lung cancer, as well as their potential importance in treating inflammatory diseases such as rheumatoid arthritis.

Through this acquisition, Roche's R&D pipeline is strengthened by Piramed's two major research programs targeting PI3-K-alpha in oncology and PI3-K-delta in inflammatory disease. The PI3-K-alpha program has a compound in phase I of clinical development and is currently being developed in collaboration with Genentech, in whom Roche has a majority ownership interest. The previously unpartnered PI3-K-delta program, while at a pre-clinical stage, will be integrated into the Roche Group's rich inflammatory R&D portfolio.

"The integration of Piramed's promising research and development reaffirms and further strengthens Roche's leadership in oncology", said William M. Burns, CEO, Roche Pharmaceuticals Division. "While innovative medicines have undoubtedly transformed cancer treatment, cancer remains a major cause of death and we are committed to investing in the development of new treatment options. In addition, this acquisition augments our research efforts in debilitating diseases such as rheumatoid arthritis."

Michael Moore, Chief Executive of Piramed, said: "Since Piramed was formed in 2003, we have struck a significant licensing deal with Genentech and advanced our highly promising first oncology product into the clinic. Today's acquisition by Roche underlines the va
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection
2. Memory Pharmaceuticals & Roche Expand Development Program for MEM 3454 in Schizophrenia
3. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
4. Roche responds to announcement of IDEAL hepatitis C trial results
5. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
6. Two Pivotal Phase III Studies for Roches ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms
7. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
8. Roche Diagnostics HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug
9. Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
10. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
11. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 23, 2014  Researchers from the North American Menopause ... elevates calcium levels too high, 1 putting women ... Women close to menopause are commonly told ... prevent diseases such as osteoporosis, to which they are ... determine how much calcium they typically get through their ...
(Date:7/23/2014)... 23, 2014  Mevesi Inc. would like to ... integration provides pharmacies with the ability to send ... patients. Mevesi,s solutions provide an ... to define target marketing campaigns. This coupled with ... within the Digital Marketing, Population Management, and Pharmacy ...
(Date:7/23/2014)... 2014 Global healthcare company GSK ... currency headwinds, increased price competition and supply disruptions to ... Witty points out that the company is very much ... to be confident about long-term prospects as well as ... CFO Simon Dingemans adds that the ...
Breaking Medicine Technology:Women Taking Too Much Calcium Create Health Risk 2Mevesi Enhances Solutions with Variable Print Media Capabilities! 2
... , , Trial taking place ... Ky., July 24 Michael (Mike) Jones has become the world,s first ... infusion on July 17 marks the world,s first phase-one FDA-approved clinical trial ... is being conducted by a team of University of Louisville physicians at ...
... , WISCONSIN RAPIDS, Wis., July 23 ... Riverview became the first medical facility in the world to ... within Riverview Hospital, Wisconsin Rapids, the UW Cancer Center Riverview ... FDA-cleared Axxent(R) Electronic Brachytherapy System from Xoft, Inc. Electronic Brachytherapy, ...
Cached Medicine Technology:World's First Cardiac Adult Stem Cell Patient Receives Infusion 2First Skin Cancer Patients Treated With Electronic Brachytherapy (eBx) At University of Wisconsin Riverview Cancer Center 2First Skin Cancer Patients Treated With Electronic Brachytherapy (eBx) At University of Wisconsin Riverview Cancer Center 3
(Date:7/23/2014)... Celebrating a decade of philanthropy in ... the awarding of $1,070,000 in grants to 20 New ... of the Foundation’s 1,000th grant. , “The Horizon Foundation ... of supporting community-based organizations that are working to improve ... the Garden State,” said Robert A. Marino, Horizon Blue ...
(Date:7/23/2014)... study supports a growing body of research suggesting ... hormones in treating postmenopausal breast cancer, with fewer ... with standard anti-hormone therapies. The study will be ... journal Reproductive Biology and Endocrinology . , ... in women in the United States. Approximately 70% ...
(Date:7/23/2014)... Global Cardio Care, Inc., a management ... (EECP), is celebrating the 100th birthday of Albert ... health center. , Weber has been plagued with ... EECP therapy since 1999, he no longer suffers from ... Global Cardio Care, introduced the Sara Soulati Health ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 The voice on the ... call that brought the news he was infected with the human ... a little bit and next thing you know I was on ... , Yet the message was hopeful when the recording ended less ... of you . . . because it is just God ...
(Date:7/23/2014)... -- For patients infected with both HIV and hepatitis ... viruses, a small study suggests. Researchers said doctors ... people with the two diseases. "The findings ... important role in the management of individuals with [hepatitis ... Sherman, a professor of medicine at the University of ...
Breaking Medicine News(10 mins):Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 2Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 3Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 4Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 5Health News:Hormones after breast cancer: Not fuel for the fire after all? 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 3Health News:Hormones after breast cancer: Not fuel for the fire after all? 4Health News:Hormones after breast cancer: Not fuel for the fire after all? 5Health News:Global Cardio Care Celebrates EECP Patient’s 100th Birthday 2Health News:HIV clinic-based audio project emphasizes the power of patient voices 2Health News:HIV clinic-based audio project emphasizes the power of patient voices 3Health News:HIV Meds May Also Help Control Hepatitis C, Study Finds 2
... finds children with sickle cell disease are more likely to ... if they live in households where people smoke.// ,Study ... harm the health of nonsmokers. It is found that exposure ... to a vast array of problems. ,In sickle ...
... show obese men with prostate cancer are at a higher ... recurrence than men of normal weight.// ,The first ... San Diego sampled nearly 3,200 prostate cancer patients. In this ... defined as having a body mass index higher than 30. ...
... valacyclovir may significantly reduce the spread of the genital ... each case, one partner was diagnosed with //type 2 ... Type 2 herpes causes a chronic genital viral infection ... herpes were given either 500 milligrams of valacyclovir once ...
... New research proves drug-coated stents effectively combat death, heart ... a closer look at the effects of drug-coated stents ... 500 patients with previously untreated blocked arteries who were ... comparable blockages were treated with bare metal stents. ...
... million service men and women before and after the Air ... rate of suicide seen among Air Force personnel. // ... for black and white males ages 24 to 35, between ... are to provide support for soldiers facing mental health or ...
... simplex virus is a common eye disease affecting people worldwide. ... cases are identified // annually. The disease is caused by ... get the infection will have repeat infections. The recurrence rate ... five years, and 67 percent within seven years. ...
Cached Medicine News:Health News:Prostate Cancer in Obese Men 2
...
Small diameter high tech flexoscopes...
... cervical plate system features an advanced design ... needs. Trinica system gives surgeons the flexibility ... unique anatomy. Flexibility is built-in to every ... and the innovative Secure-Twist anti-migration system to ...
... intended for supportive stabilization of the ... The device utilizes bi-cortical fixation for ... enhanced through dynamic screw holes and ... level interbody fusion. Anterior cervical corpectomy. ...
Medicine Products: